TFA Therapeutics RAJAF
OTC RAJAF
$9.18 +0.00 (+0.00%)
At close: Sep 29, 2026 · 4:00 PM EDT

TFA Therapeutics (RAJAF) Gross Margin (2023)

Updated

TFA Therapeutics (RAJAF) posted Gross Margin of 61.09% for FY2025, down 11.23 percentage points from 72.32% in FY2024.

Analysis

TFA Therapeutics (RAJAF) Gross Margin (2023) Analysis & Trends

Since FY2020, TFA Therapeutics has reported Gross Margin for 6 years.

  • Annual Gross Margin shows a five-year change of -8.74 percentage points (FY2020 to FY2025).
  • The FY2025 figure stands as the lowest annual Gross Margin since FY2021.
  • Business Quant data shows RAJAF's Gross Margin at 72.32% in FY2024 (-14.52 pp), 86.84% in FY2023 (+12.63 pp), 74.21% in FY2022 (+94.25 pp) and -20.04% in FY2021 (-89.87 pp).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gross Margin (Qtr)
1 Procter & Gamble 337.81 Bn 293.80 Bn 10.28 Bn 48.50%
2 Colgate Palmolive 68.01 Bn 63.06 Bn 3.30 Bn 61.48%
3 Kenvue 33.93 Bn 29.54 Bn 2.30 Bn 58.18%
4 Estee Lauder Companies 33.63 Bn 21.70 Bn 2.74 Bn 75.46%
5 Kimberly Clark 32.41 Bn 29.73 Bn 1.60 Bn 38.27%
6 Church & Dwight 22.35 Bn 20.88 Bn 693.90 Mn 45.35%
7 Clorox 9.80 Bn 8.24 Bn 804.00 Mn 41.27%
8 e.l.f. Beauty 5.95 Bn 4.92 Bn 398.84 Mn 83.20%
9 Reynolds Consumer Products 4.56 Bn 4.22 Bn 245.00 Mn 25.95%
10 TFA Therapeutics 1.02 Bn 1.02 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2023 90.22%
API Access

TFA Therapeutics Gross Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gross-margin&ticker=RAJAF&period=max&api_key=YOUR_API_KEY